Ian F. Smith - Mar 20, 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Interim CEO, Director
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Mar 20, 2025
Transactions value $
$0
Form type
4
Date filed
3/20/2025, 06:19 PM
Previous filing
Jan 7, 2025
Next filing
Apr 8, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Stock Option (Right to Buy) Award $0 +238K $0.00 238K Mar 20, 2025 Common Stock 238K $8.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests ratably as to 1/12 of the total award on the monthly anniversary of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.